123 related articles for article (PubMed ID: 19912987)
1. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
Yu J; Deng M; Zhao J; Huang L
Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
[TBL] [Abstract][Full Text] [Related]
2. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
5. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
[TBL] [Abstract][Full Text] [Related]
6. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Bro S; Bentzon JF; Falk E; Andersen CB; Olgaard K; Nielsen LB
J Am Soc Nephrol; 2003 Oct; 14(10):2466-74. PubMed ID: 14514724
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
Maizel J; Six I; Slama M; Tribouilloy C; Sevestre H; Poirot S; Giummelly P; Atkinson J; Choukroun G; Andrejak M; Kamel S; Mazière JC; Massy ZA
Circulation; 2009 Jan; 119(2):306-13. PubMed ID: 19118252
[TBL] [Abstract][Full Text] [Related]
9. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
[TBL] [Abstract][Full Text] [Related]
10. An oral sorbent, AST-120, increases Klotho expression and inhibits cell senescence in the kidney of uremic rats.
Adijiang A; Niwa T
Am J Nephrol; 2010; 31(2):160-4. PubMed ID: 19955715
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
12. The klotho gene: a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism.
Negri AL
J Nephrol; 2005; 18(6):654-8. PubMed ID: 16358222
[TBL] [Abstract][Full Text] [Related]
13. Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
Mori Y; Hirano T; Nagashima M; Shiraishi Y; Fukui T; Adachi M
Metabolism; 2007 Dec; 56(12):1714-8. PubMed ID: 17998026
[TBL] [Abstract][Full Text] [Related]
14. Uremia modulates the phenotype of aortic smooth muscle cells.
Madsen M; Aarup A; Albinsson S; Hartvigsen K; Sørensen CM; Turczynska K; Nielsen LB; Pedersen TX
Atherosclerosis; 2017 Feb; 257():64-70. PubMed ID: 28107707
[TBL] [Abstract][Full Text] [Related]
15. Severely reduced production of klotho in human chronic renal failure kidney.
Koh N; Fujimori T; Nishiguchi S; Tamori A; Shiomi S; Nakatani T; Sugimura K; Kishimoto T; Kinoshita S; Kuroki T; Nabeshima Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):1015-20. PubMed ID: 11162628
[TBL] [Abstract][Full Text] [Related]
16. Identification of pathways for atherosclerosis in mice: integration of quantitative trait locus analysis and global gene expression data.
Wang SS; Schadt EE; Wang H; Wang X; Ingram-Drake L; Shi W; Drake TA; Lusis AJ
Circ Res; 2007 Aug; 101(3):e11-30. PubMed ID: 17641228
[TBL] [Abstract][Full Text] [Related]
17. Effects of apolipoprotein M in uremic atherosclerosis.
Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
[TBL] [Abstract][Full Text] [Related]
18. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
[TBL] [Abstract][Full Text] [Related]
19. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
Harrington SC; Simari RD; Conover CA
Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
[TBL] [Abstract][Full Text] [Related]
20. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
